Cre recombinase and other tyrosine recombinases

G Meinke, A Bohm, J Hauber, MT Pisabarro… - Chemical …, 2016 - ACS Publications
Tyrosine-type site-specific recombinases (T-SSRs) have opened new avenues for the
predictable modification of genomes as they enable precise genome editing in heterologous …

Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN

QU Ain, JY Chung, YH Kim - Journal of Controlled Release, 2015 - Elsevier
Gene therapy by engineered nucleases is a genetic intervention being investigated for
curing the hereditary disorders by targeting selected genes with specific nucleotides for …

Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cells

J Liu, T Gaj, Y Yang, N Wang, S Shui, S Kim… - Nature protocols, 2015 - nature.com
Targeted nucleases, including zinc-finger nucleases (ZFNs), transcription activator-like
(TAL) effector nucleases (TALENs) and clustered regularly interspaced short palindromic …

Efficient recombinase-mediated cassette exchange in hPSCs to study the hepatocyte lineage reveals AAVS1 locus-mediated transgene inhibition

L Ordovás, R Boon, M Pistoni, Y Chen, E Wolfs, W Guo… - Stem cell reports, 2015 - cell.com
Tools for rapid and efficient transgenesis in" safe harbor" loci in an isogenic context remain
important to exploit the possibilities of human pluripotent stem cells (hPSCs). We created …

Using artificial microRNA sponges to achieve microRNA loss-of-function in cancer cells

FC Tay, JK Lim, H Zhu, LC Hin, S Wang - Advanced drug delivery reviews, 2015 - Elsevier
Widely observed dysregulation of microRNAs (miRNAs) in human cancer has led to
substantial speculation regarding possible functions of these short, non-coding RNAs in …

iPS cell technologies and cartilage regeneration

N Tsumaki, M Okada, A Yamashita - Bone, 2015 - Elsevier
Articular cartilage covers the ends of bone and provides shock absorption and lubrication to
the diarthrodial joints. Cartilage has a limited capacity for repair when injured, and there is a …

Development of a baculoviral CRISPR/Cas9 vector system for beta-2-microglobulin knockout in human pluripotent stem cells

Z Xiang, Q Ye, Z Zhao, N Wang, J Li, M Zou… - Molecular Genetics and …, 2024 - Springer
Derivation of hypoimmunogenic human cells from genetically manipulated pluripotent stem
cells holds great promise for future transplantation medicine and adoptive immunotherapy …

May I cut in? Gene editing approaches in human induced pluripotent stem cells

N Brookhouser, S Raman, C Potts, DA Brafman - Cells, 2017 - mdpi.com
In the decade since Yamanaka and colleagues described methods to reprogram somatic
cells into a pluripotent state, human induced pluripotent stem cells (hiPSCs) have …

Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells

SY Tang, S Zha, Z Du, J Zeng, D Zhu, Y Luo… - Stem cell research & …, 2021 - Springer
Background Redirection of natural killer (NK) cells with chimeric antigen receptors (CAR) is
attractive in developing off-the-shelf CAR therapeutics for cancer treatment. However, the …

Applications of CRISPR-Cas in bioengineering, biotechnology, and translational research

CH Lau - The CRISPR journal, 2018 - liebertpub.com
CRISPR technology is rapidly evolving, and the scope of CRISPR applications is constantly
expanding. CRISPR was originally employed for genome editing. Its application was then …